Article

Daily Medication Pearl: Seizalam

Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults.

Medication Pearl of the Day: Midazolam injection (Seizalam)

Indication: Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults.

Insight:

  • Dosing: Injection: 50 mg/10 mL (5 mg/mL) in a multiple-dose vial.
  • Dosage forms: The recommended dose is 10 mg, administered by intramuscular injection.
  • Adverse events: The most common adverse reactions (incidence >3%) in clinical trials in patients with status epilepticus were upper airway obstruction, agitation, and pyrexia.
  • Mechanism of action: The exact mechanism of action for midazolam in the treatment of status epilepticus is not fully understood but is thought to involve potentiation of GABAergic neurotransmission resulting from binding at the benzodiazepine site of the GABAA receptor.

Source: label (fda.gov)

Related Videos
Senior Doctor is examining An Asian patient.
Healthcare, pharmacist and woman at counter with medicine or prescription drugs sales at drug store.
Image Credit: © Birdland - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought